ADMET prediction and drug-likeness filtering is the computational assessment of a compound's Absorption, Distribution, Metabolism, Excretion, and Toxicity properties, coupled with the application of physicochemical rules and predictive models to eliminate unsuitable molecules from early-stage drug discovery pipelines.
This skill is highly valued because it directly reduces costly late-stage clinical failures by filtering out problematic compounds early, thereby saving hundreds of millions in R&D investment and accelerating the progression of viable candidates. It transforms discovery from a high-risk gamble into a more predictive, resource-efficient process.
1Careers
1Categories
9.2 Avg Demand
15%
Avg AI Risk
How to Learn ADMET prediction and drug-likeness filtering
Focus on: 1) Core physicochemical descriptors (LogP, molecular weight, polar surface area, hydrogen bond donors/acceptors) and classical rules like Lipinski's Rule of Five. 2) Basic pharmacokinetic concepts (clearance, volume of distribution, bioavailability). 3) Fundamental toxicity endpoints (hERG inhibition, hepatotoxicity alerts).
Move to building and interpreting quantitative structure-activity relationship (QSAR) and machine learning models using libraries like scikit-learn or DeepChem. Practice applying these models to public datasets (e.g., ChEMBL) for specific ADMET endpoints. Common mistake: over-reliance on single-parameter filters; instead, learn to create weighted, multi-parameter scoring functions.
Master the integration of heterogeneous data (in vitro, in vivo, clinical PK) to build robust, human-relevant PBPK models. Develop strategies for de-risking multi-parameter optimization (MPO) trade-offs. Architect end-to-end in silico ADMET workflows that inform go/no-go decisions in cross-functional project teams.
Practice Projects
Beginner
Project
Compound Filtering Pipeline with Open Source Tools
Scenario
You have a virtual library of 10,000 compounds from a hit-finding campaign. Your task is to apply a standard drug-likeness filter to reduce the list to under 1,000 compounds for purchase or synthesis.
How to Execute
1. Install RDKit and Pandas in a Python environment. 2. Load the compound library from an SDF or SMILES file. 3. Write a script to calculate key descriptors (MW, LogP, HBD, HBA, TPSA) for each molecule. 4. Apply Lipinski's and Veber's rules as filters, then save the filtered set and analyze the distribution of the rejected compounds.
Intermediate
Project
Build and Validate a Hepatotoxicity QSAR Model
Scenario
Your team needs a preliminary in-house model to flag potential hepatotoxic compounds before they enter expensive in vitro testing.
How to Execute
1. Source a curated dataset for DILI (Drug-Induced Liver Injury) from sources like the Liver Toxicity Knowledge Base (LTKB). 2. Perform feature engineering using RDKit descriptors and fingerprints. 3. Train and cross-validate a Random Forest or XGBoost classifier. 4. Evaluate performance using metrics like precision-recall AUC and applicability domain analysis, then document the model's limitations for stakeholders.
Advanced
Project
Design a Multi-Parameter Optimization (MPO) Scoring Workflow for a Lead Series
Scenario
You are optimizing a lead series where improving potency often worsens metabolic stability. You need to design a computational workflow that balances multiple ADMET parameters to select the best compounds for synthesis.
How to Execute
1. Define the project's specific MPO objective function with weights (e.g., potency, clearance, permeability, solubility). 2. Train or select validated predictive models for each parameter. 3. Integrate models into a pipeline that scores all analogs in the design-make-test cycle. 4. Use Pareto front analysis to visualize trade-offs and present clear recommendations to the medicinal chemistry team.
Tools & Frameworks
Software & Libraries
RDKitDeepChemSchrödinger Suite (QikProp, Prime)KNIME Analytics Platform with ChEMBL Nodes
RDKit is the open-source standard for cheminformatics and descriptor calculation. DeepChem provides state-of-the-art deep learning models for ADMET. Schrödinger's commercial platform offers validated, integrated tools for property prediction. KNIME enables building no-code/low-code predictive workflows.
Data Sources & Databases
ChEMBLPubChemDrugBankADMETlab 2.0/3.0eTOX
ChEMBL and PubChem provide large-scale bioactivity and chemical structure data for model training. DrugBank offers curated drug and ADMET data. ADMETlab is a specialized web server with pre-built models. eTOX provides high-quality in vivo toxicity data from legacy studies.
QSAR models correlate structure to endpoints. PBPK models simulate whole-body PK. MPO scoring synthesizes multiple predictions into a single rank. Read-across is used for data-poor scenarios, especially in toxicology, to predict properties based on chemical similarity.
Interview Questions
Answer Strategy
The interviewer is testing your understanding of structure-property relationships and your ability to apply targeted computational design. Strategy: Use molecular interaction fields or structure-based design to identify metabolically soft spots, then propose bioisosteric replacements at those sites while monitoring changes in lipophilicity and polar surface area. Sample Answer: 'I would first use a metabolism site-of-metabolism prediction tool like WhichP450 to identify vulnerable sites. Then, I'd leverage a bioisostere library to propose replacements that block metabolism, such as replacing a labile methyl group with a trifluoromethyl or a metabolically stable heterocycle. I would simultaneously run the proposed structures through a PBPK model to verify that the increased stability translates to improved exposure without a detrimental reduction in distribution due to increased polarity.'
Answer Strategy
This behavioral question assesses your scientific rigor, critical thinking, and learning agility. Core competency: intellectual honesty and problem-solving. Sample Answer: 'In one project, a P-glycoprotein efflux model predicted low efflux liability for a compound, but cellular assays showed high efflux. I diagnosed the issue by first checking the model's applicability domain; the compound had a substructure poorly represented in the training data. I then performed a structural alert search and found a known efflux-triggering motif the model missed. I learned two key things: always validate the model's chemical space coverage for new scaffolds, and to use orthogonal methods like molecular docking to P-gp crystal structures when simple descriptors are ambiguous.'
Careers That Require ADMET prediction and drug-likeness filtering